Some characteristics of pharmaceuticals make them comparable to software. Basically software and pharmaceuticals have:
For example, both require a large, upfront resource investment in research and composition. After initial R&D expenses, both are relatively easily manufactured and distributed at scale.
Knowing this, pharmaceuticals may be well placed to leverage wide-reaching treatments while reducing healthcare costs. Additionally, with precision medicine , highly-focused solutions can be developed or even compounded on-demand for individual use to increase effectiveness.
Risks to consider are that while pharmaceuticals and software may share characteristics, they are not the same in execution - human risks are significantly higher in the medical space than those typically found in software and this should not be discounted.
I wonder how we can further “software-ize” pharma…